The Use of Fluorescent Anti-CEA Antibodies to Label, Resect and Treat Cancers: A Review

A major barrier to the diagnosis and effective treatment of solid-tumor cancers is the difficulty in detection and visualization of tumor margins in primary and metastatic disease. The use of fluorescence can augment the surgeon’s ability to detect cancer and aid in its resection. Several cancer typ...

Descripción completa

Detalles Bibliográficos
Autores principales: Turner, Michael A., Lwin, Thinzar M., Amirfakhri, Siamak, Nishino, Hiroto, Hoffman, Robert M., Yazaki, Paul J., Bouvet, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699160/
https://www.ncbi.nlm.nih.gov/pubmed/34944463
http://dx.doi.org/10.3390/biom11121819

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699160/
https://www.ncbi.nlm.nih.gov/pubmed/34944463
http://dx.doi.org/10.3390/biom11121819

Ejemplares similares